| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.029 | 0.8 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.8 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.043 | 0.8 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.026 | 0.8 |